No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | Pharmacountry

Products
Finished Dosage Forms
Tablets
Immediate-Release Tablets

ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

AP

Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An

Marketing Authorization Holder · Finished Dosage FormsItaly

Basic Information

Category

Subcategory & Sub-subcategory

/

Trade Type

Sell

Product Name

ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Details

•

Substance

Registered Market

Distributor(s)

- .

Specifications

Dosage Form: Tablet
ATC Code: N03AX25
Packaging: ONTOZRY 12,5 mg tablets + ONTOZRY 25 mg tablets film-coated, 28 tablets (14 x 25 mg + 14 x 12,5 mg)

Documents

Drug Marketing Authorization Number

Document No.: 1211530001

Issue Date: Jun 2, 2021

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Finished Dosage Forms

Immediate-Release Tablets

CENOBAMATO 12,5 mg

CENOBAMATO 25 mg

Angelini Pharma Espana S.L.